Speclipse
PrivateLast Round
Private Equity
Jul 1, 2024
Total Funding Raised
$39.1M
Company Overview
Speclipse is a medical technology company that develops AI-powered laser spectroscopy systems for skin cancer diagnosis and aesthetic medical applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Speclipse Comparables
Compare Speclipse with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DermaSensor, Inc. | 86% | |
| Vita Imaging Inc. | 84% | |
| Scibase Holding | 80% |
Speclipse Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Jul 1, 2024 | ||||
| Series A | Aug 19, 2021 | ||||
| Corporate Funding | Nov 5, 2019 | ||||
| Seed | Nov 1, 2016 |
Key People
Founding team and executive leadership
Speclipse Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InterVest | Seed |
| Lindeman Asia Investment | Corporate Funding |
| BNH INVESTMENT | Series A |
| K2 Investment Partners | Private Equity |
| SBVA | Seed |
| JB Investment | Seed |
| Signite Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2016
$2.6M raised from InterVest, JB Investment, and SBVA.
Speclipse Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Speclipse's valuation, stock price, and market status.
Is Speclipse a public or private company?
Speclipse is a private company.
What is the current stock price of Speclipse?
Speclipse is a private company with no public stock price. No recent secondary market data is available.
How much is Speclipse worth (valuation)?
Valuation information for Speclipse is not publicly available.
Can I buy Speclipse stock?
Speclipse shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Speclipse's last funding round?
Speclipse's most recent funding round was Private Equity on July 1, 2024.
Who are the main investors in Speclipse?
Key investors in Speclipse include Signite Partners.
Will Speclipse IPO soon?
No public IPO plans have been announced for Speclipse.
How can I track Speclipse secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Speclipse's secondary market activity and sign up for updates.